1. Augmentation of the antitumor effects of PARP inhibitors in triple-negative breast cancer via degradation by hydrophobic tagging modulation
- Author
-
Woori Lee, Hyun-Jin Kim, Jeong Woon Jang, Jae Du Ha, Ahra Go, and Hye Jin Nam
- Subjects
Proteasome Endopeptidase Complex ,Poly (ADP-Ribose) Polymerase-1 ,Antineoplastic Agents ,Apoptosis ,Triple Negative Breast Neoplasms ,Poly(ADP-ribose) Polymerase Inhibitors ,Protein degradation ,01 natural sciences ,Piperazines ,Olaparib ,03 medical and health sciences ,chemistry.chemical_compound ,PARP1 ,Breast cancer ,Drug Discovery ,medicine ,Humans ,Triple-negative breast cancer ,030304 developmental biology ,Pharmacology ,0303 health sciences ,010405 organic chemistry ,Organic Chemistry ,General Medicine ,medicine.disease ,0104 chemical sciences ,chemistry ,Proteolysis ,PARP inhibitor ,Unfolded Protein Response ,Unfolded protein response ,Cancer research ,Phthalazines ,Female ,Ovarian cancer ,Hydrophobic and Hydrophilic Interactions - Abstract
Triple-negative breast cancer (TNBC) has an aggressive phenotype and poor prognosis due to the lack of specific targeted treatments. The development of an effective therapeutic strategy with a novel mechanism is essential for TNBC management. Olaparib, a PARP inhibitor, has been approved for the treatment of breast or ovarian cancer patients with breast cancer gene 1/2 (BRCA1/2) mutations. Here, we report the development of a small molecule targeting PARP1 based on the hydrophobic tagging (HyT) method. Targeted protein misfolding and consequent degradation are caused by HyT. Hydrophobic-tagged olaparib induces the proteasome-dependent degradation of PARP1 and shows enhanced antitumor effects compared to olaparib in TNBC cells. In addition, hydrophobic-tagged olaparib causes ER stress-related unfolded protein response (UPR), autophagy, and apoptosis. These results point towards encouraging prospects for chemically modifying approved drugs that not only exhibit superior effects compared to those of the original drugs by triggering novel mechanisms but also provide great feasibility in the translational scenario.
- Published
- 2020
- Full Text
- View/download PDF